These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8404631

  • 1. Evidence that neuropeptide Y could represent a neuroendocrine inhibitor of sexual maturation in unfavorable metabolic conditions in the rat.
    Gruaz NM, Pierroz DD, Rohner-Jeanrenaud F, Sizonenko PC, Aubert ML.
    Endocrinology; 1993 Oct; 133(4):1891-4. PubMed ID: 8404631
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.
    Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F, Rivier JE, Sizonenko PC, Aubert ML.
    Endocrinology; 1993 Jan; 132(1):224-34. PubMed ID: 8380374
    [Abstract] [Full Text] [Related]

  • 3. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.
    Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML.
    Endocrinology; 1996 Jan; 137(1):3-12. PubMed ID: 8536627
    [Abstract] [Full Text] [Related]

  • 4. Chronic administration of neuropeptide Y into the lateral ventricle starting at 30 days of life delays sexual maturation in the female rat.
    Pierroz DD, Gruaz NM, d'Alièves V, Aubert ML.
    Neuroendocrinology; 1995 Mar; 61(3):293-300. PubMed ID: 7898634
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone (GH) deprivation induced by passive immunization against rat GH-releasing factor does not disturb the course of sexual maturation and fertility in the female rat.
    Gruaz NM, Arsenijevic Y, Wehrenberg WB, Sizonenko PC, Aubert ML.
    Endocrinology; 1994 Aug; 135(2):509-19. PubMed ID: 7518382
    [Abstract] [Full Text] [Related]

  • 6. The neuropeptide Y Y1 receptor mediates NPY-induced inhibition of the gonadotrope axis under poor metabolic conditions.
    Gonzales C, Voirol MJ, Giacomini M, Gaillard RC, Pedrazzini T, Pralong FP.
    FASEB J; 2004 Jan; 18(1):137-9. PubMed ID: 14597564
    [Abstract] [Full Text] [Related]

  • 7. Evidence for a leptin-neuropeptide Y axis for the regulation of growth hormone secretion in the rat.
    Vuagnat BA, Pierroz DD, Lalaoui M, Englaro P, Pralong FP, Blum WF, Aubert ML.
    Neuroendocrinology; 1998 May; 67(5):291-300. PubMed ID: 9641610
    [Abstract] [Full Text] [Related]

  • 8. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
    Xu B, Dube MG, Kalra PS, Farmerie WG, Kaibara A, Moldawer LL, Martin D, Kalra SP.
    Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
    Schwartz MW, Sipols AJ, Marks JL, Sanacora G, White JD, Scheurink A, Kahn SE, Baskin DG, Woods SC, Figlewicz DP.
    Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
    [Abstract] [Full Text] [Related]

  • 10. Leptin reduces food intake but does not alter weight regain following food deprivation in the rat.
    Velkoska E, Morris MJ, Burns P, Weisinger RS.
    Int J Obes Relat Metab Disord; 2003 Jan; 27(1):48-54. PubMed ID: 12532153
    [Abstract] [Full Text] [Related]

  • 11. Effects of constant infusion with insulin-like growth factor-I (IGF-I) to immature female rats on body weight gain, tissue growth and sexual function. Evidence that such treatment does not affect sexual maturation of fertility.
    Gruaz NM, d'Allèves V, Charnay Y, Skottner A, Ekvärn S, Fryklund L, Aubert ML.
    Endocrine; 1997 Feb; 6(1):11-9. PubMed ID: 9225110
    [Abstract] [Full Text] [Related]

  • 12. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis.
    Sahu A, Dube MG, Phelps CP, Sninsky CA, Kalra PS, Kalra SP.
    Endocrinology; 1995 Dec; 136(12):5718-24. PubMed ID: 7588328
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
    Crowley WR, Ramoz G, Keefe KA, Torto R, Kalra SP, Hanson GR.
    Neuroscience; 2005 Dec; 132(1):167-73. PubMed ID: 15780475
    [Abstract] [Full Text] [Related]

  • 17. Synergistic action by neuropeptide Y (NPY) and norepinephrine (NE) on food intake, metabolic rate, and brown adipose tissue (BAT) causes remarkable weight loss in the obese (fa/fa) Zucker rat.
    al-Arabi A, Andrews JF.
    Biomed Sci Instrum; 1997 Dec; 33():216-25. PubMed ID: 9731362
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
    Raposinho PD, Castillo E, d'Alleves V, Broqua P, Pralong FP, Aubert ML.
    Endocrinology; 2000 Dec; 141(12):4419-27. PubMed ID: 11108250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.